Join us for a webinar designed to help covered entities understand and apply the core compliance requirements of the 340B Drug Pricing Program. Participants will learn how to put these core principles into practice through everyday scenarios, use available tools, better identify potential compliance risks, and know how to effectively respond to risks.
Objectives:
Why Attend?
Participants will learn key requirements, common pitfalls, and best practices for maintaining 340B program integrity. Attendees will apply practical tools to strengthen oversight and audit readiness.
Key Benefits Include:
Participant Knowledge Level: Basic/Intermediate
Target Audience: All 340B Stakeholders
Event Date: Wednesday, August 13, 12:00–1:00 p.m. CT
The webinar will not be recorded.
Xan Janiga, PharmD, BCPS, 340B ACE
Director, 340B Compliance
Apexus
Natalie Russell, PharmD, MBA, MSHA, BCPS, 340B ACE
Director, 340B Compliance
Apexus
Use this sample data request list (DRL) to prepare for a HRSA 340B audit.
Outlines a sample self-audit method for CHCs/FQHCs to ensure that diversion safeguards are in place under 340B.
Highlights a sample self-audit approach to assist hospitals in monitoring compliance with 340B duplicate discount requirements under the GPO Prohibition.
Illustrates how rural hospitals can structure internal reviews to address duplicate discount risks.
Provides a sample self-audit framework to help hospitals address diversion risks and maintain compliance with the GPO Prohibition under 340B.
Guides CHCs/FQHCs through a sample review to ensure that safeguards against duplicate discounts are in place.
Inform HRSA and manufacturer of 340B noncompliance and provide corrective action plan.
